Our data demonstrated for the first time on primary GBM-derived endothelial cells, a great ability of calpain inhibitors and calpastatin to slow down GEC proliferation and survival, by inducing also apoptotic mechanisms mediated by caspase-3 and caspase-7 activation. The gene discussed is CASP3; the disease is glioblastoma.